| PRODUCT DESCRIPTION |
| ACYCLOVIR |
| PIPERAZINE 68% AQ BULK |
| PIPERAZINE 68% AQ BULK |
| PIPERAZINE 68% AQ BULK |
| N-METHYL PIPERAZINE (ADC LIST SL NO.1113 ) |
| FURAN |
| EP-A0350020 ALLOPURINOL IMPURITY B (10 MG) |
| EP-Y0001197 CETIRIZINE FOR PEAK IDENTIFICATION (1.01 MG) |
| THIOBARBITURIC ACID REAGENT FOR SORBIC ACID 2X25GMS |
| 108650050 1-(4-CHLOROBENZHYDRYL)PIPERAZINE, 90-95% |
| REFERENCE STANDARD : D,L-O-DESMETHYL VENLAFAXINE-D6 |
| REFERENCE STANDARD : FUMARIC ACID MONOMETHYL ESTER-D5 |
| 5-(2R)-2-OXIRANYL-8-BENZYLOXY-2(1H)-QUINOLINONE |
| REFERENCE STANDARD : D,L-O-DESMETHYL VENLAFAXINE |
| ADENINE |
| 15630080 100ML HEPES(HETEROCYCLIC COMPDSPYRIMOTHR) |
| 9-[2-(PHOSPHONYL METHOXY)PROPYL] ADENINE |
| THIOMORPHOLINE |
| DIHYDROARTEMISININ (FOR R&D UNIT ONLY) |
| 2,3-DIHYDROFURAN CAS NO 1191-99-7 |
| N-METHYL PIPERAZINE |
| PALIPERIDONE |
| N-ALANYL-L-HISTIDINE |
| BOC-L-2-AMINOBUTYRIC ACID |
| Z-GLN(TRT)-OH |
| USP-1711133 LYPRESSIN - (2 MG)-ALL ABOVE ITEMS ARE PHARMACEUTICAL REFERENCE STANDARDS(PRS)ASST/DUTY UNDER PROTEST |
| 15630080 100ML HEPES(HETEROCYCLIC COMPDS PYRIM OTHR) |
| MINOXIDIL IP |
| MINOXIDIL IP |
| 5-BROMOINDOLINE |
| 4-IODO-3-METHYLBENZOIC ACID |
| (1-ETHOXYCARBONYLETHYLETHYLIDENE)TRIPHENYL PHOSPORANE |
| A14003.72 1,4-DIAZABICYCLO[2.2.2]OCTANE, 98% |
| BUTYL METHANESULFONATE |
| A14003.TW 1,4-DIAZABICYCLO[2.2.2]OCTANE, 98% |
| METHYL 5-BROMO-2-FLUOROBENZOATE |
| 3-CHLOROBENZALDEHYDE |
| CYCLOHEXANESULFONAMIDE |
| MINOXIDIL IP |
| ADENINE |
| MINOXIDIL IP |
| 4-CHLORO-6-ETHYL-5-FLUORO PYRIMIDINE |
| 3,4-DIFLUOROBENZALDEHYDE |
| 3-BROMOPROPIONAMIDE |
| OXCARBAZEPINE |
| 4,6-DICHLORO-2-PROPYLTHIOPYRIMIDINE-5-AMINE |
| CYCLOPROPYLHYDRAZINE HYDROCHLORIDE |
| 10 KGS OF 4 6 DICHLOROPYRIMIDINE (FOR R & D PURPOSE FOR DEVELOPMENT OF AGROCHEMICAL FOR CAPTIVE USE NOT FOR SALE) |
| L-VALINOL |
| CYTARABINE IP/BP/EP (LIST-3,S.NO.126)(BATCH NO. IB1600148ADOM. 11/05/ 2016, DOE. 05/ 2021) |